Physical Therapists in Azle, TX Accepting Medicare

10 Physical Therapists found. Showing 1 - 10

Caitlynn Perry, DPY Physical Therapist Medicare: Medicare Enrolled Practice Location: 245 W Main St, Azle, TX 76020 Phone: 817-270-2975    Fax: 817-270-3596

Northwest Physical Therapy Inc Physical Therapist Medicare: Medicare Enrolled Practice Location: 408 Central Dr, Azle, TX 76020 Phone: 817-444-8827

Kelsey Robers Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 245 W Main St, Azle, TX 76020 Phone: 817-270-2975

Jeremy Corbin, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 137 Industrial Ave, Azle, TX 76020 Phone: 817-270-2975    Fax: 817-370-9891

Alex Gustaf, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 137 Industrial Ave Ste B, Azle, TX 76020 Phone: 817-270-2975    Fax: 817-270-3596

Kurt Dinkle Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 721 Dunaway Ln, Azle, TX 76020 Phone: 409-782-6060

Andrew Sewell, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 137 Industrial Ave, Azle, TX 76020 Phone: 817-270-2975

Ashley Renegar Physical Therapist - Geriatrics Medicare: Not Enrolled in Medicare Practice Location: 721 Dunaway Ln, Azle, TX 76020 Phone: 817-444-2536

Jared May, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 245 W Main St, Azle, TX 76020 Phone: 817-270-2975    Fax: 817-270-3596

Thomas L Reid Jr., LPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 408 Central Dr, Azle, TX 76020 Phone: 817-444-8827    Fax: 817-444-8847

News Archive

Two drug combinations may provide new treatment option for patients with pancreatic cancers

Two drug combinations that simultaneously block two major signaling pathways downstream of the protein KRAS, which is aberrantly active in most pancreatic cancers, may provide a new treatment option for patients with this disease, according to preclinical results presented here at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, held Oct. 19-23.

UH Case Medical Center researchers find that coenzyme A plays key role in cell metabolism

Case Western Reserve and University Hospitals Case Medical Center researchers and physicians have discovered that the molecule known as coenzyme A plays a key role in cell metabolism by regulating the actions of nitric oxide. Cell metabolism is the ongoing process of chemical transformations within the body's cells that sustains life, and alterations in metabolism are a common cause of human disease, including cancer and heart disease.

Promising clinical trial for Progeria "premature aging" disease

One of the fastest translations of a basic research discovery into a promising clinical trial for an "untreatable" and fatal disorder will be discussed publicly for the first time by the key players in this remarkable research story, on Sunday, Dec. 14, at the American Society for Cell Biology (ASCB)'s annual meeting in San Francisco.

Australian reimbursement committee is set to consider Novo Nordisk's type 2 diabetes treatment

In its November meeting, the Pharmaceutical Benefits Advisory Committee (PBAC) will consider Novo Nordisk's second-to-market glucagon-like peptide-1 (GLP-1) agonist Victoza for reimbursement, which would be essential in order for the drug to compete effectively with Eli Lilly's Byetta. However, its chances of success are uncertain, considering that it took three years to get Byetta on the Pharmaceutical Benefits Scheme (PBS).

NCPA supports proposal for adopting PBM transparency

The National Community Pharmacists Association (NCPA) today praised U.S. Sen. Maria Cantwell (D-WA) for authoring an amendment to lower health care costs by adopting common-sense disclosure requirements for any pharmacy benefit manager (PBM) participating in the health insurance exchanges envisioned under a proposal by Sen. Max Baucus (D-MT).

Read more Medical News

› Verified 4 days ago